Department of Colorectal Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Tumor Hospital, Kunming, China.
BMC Cancer. 2022 Nov 8;22(1):1151. doi: 10.1186/s12885-022-10182-6.
miR-145-5P is generally considered as a tumor suppressor at early stage of colorectal cancer, but up-regulation occurs in the progressive and later stages which is associated with metastasis, indicating miR-145-5p may play dual role in colorectal cancer (CRC). To explore the detailed mechanism of miR-145-5p in carcinogenic is of importance.
The expression pattern of miR-145-5p in CRC patients was downloaded from TCGA database, and the probable mechanism involved in the carcinogenic effect of miR-145-5p was predicted by bioinformatics analysis. Then, interference of miR-145-5p on SW480 and SW620 cells was conducted, and the influences on tumor cell viability, invasion ability, epithelial-mesenchymal transition (EMT), anoikis, and relative protein expression were examined respectively.
A total of 522 CRC patients' data indicated that miR-145-5p expression was significantly higher in metastatic CRC than that in non-metastatic CRC, and higher expression of miR-145-5p was correlate with worse prognosis. Overexpression of miR-145-5P-5p enhanced the proliferation and invasion ability of SW620, but inhibited them in SW480. EMT was induced in SW620 after miR-145-5p overexpression and mesenchymal-epithelial transition (MET) was induced in SW480, resulted in the decreased apoptotic rate in SW620 and elevated apoptotic rate in SW480 respectively. Western blot results showed that AKT signaling pathway was involved in the miR-145-5p evoked EMT-mediated anoikis process in SW620 and SW480 cells.
miR-145-5p is a tumor suppressor at early stage of CRC, and an oncogene at advanced stage of CRC. AKT signaling evoked EMT-mediated anoikis might be the pathway by which miR-145-5P regulates CRC cell invasion and metastasis.
miR-145-5P 通常被认为是结直肠癌早期的肿瘤抑制因子,但在进展期和晚期出现上调,与转移相关,表明 miR-145-5p 可能在结直肠癌(CRC)中发挥双重作用。探讨 miR-145-5p 在致癌中的详细机制具有重要意义。
从 TCGA 数据库下载 CRC 患者的 miR-145-5p 表达谱,通过生物信息学分析预测 miR-145-5p 致癌作用涉及的可能机制。然后,对 SW480 和 SW620 细胞进行 miR-145-5p 干扰,分别检测对肿瘤细胞活力、侵袭能力、上皮间质转化(EMT)、失巢凋亡以及相对蛋白表达的影响。
共 522 例 CRC 患者的数据表明,转移性 CRC 中 miR-145-5p 的表达明显高于非转移性 CRC,miR-145-5p 高表达与预后不良相关。miR-145-5P-5p 的过表达增强了 SW620 的增殖和侵袭能力,但抑制了 SW480 的增殖和侵袭能力。miR-145-5p 过表达诱导 SW620 发生 EMT,诱导 SW480 发生间充质上皮转化(MET),导致 SW620 细胞凋亡率降低,SW480 细胞凋亡率升高。Western blot 结果表明,AKT 信号通路参与了 miR-145-5p 诱导的 EMT 介导的失巢凋亡过程。
miR-145-5p 在 CRC 的早期是一种肿瘤抑制因子,在晚期是一种癌基因。AKT 信号通路诱导的 EMT 介导的失巢凋亡可能是 miR-145-5P 调节 CRC 细胞侵袭和转移的途径。